Identification of therapeutic drugs against COVID-19 through computational investigation on drug repurposing and structural modification

Global prevalence of coronavirus disease 2019 (COVID-19) calls for an urgent development of anti-viral regime. Compared with the development of new drugs, drug repurposing can significantly reduce the cost, time, and safety risks. Given the fact that coronavirus harnesses spike protein to invade hos...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Yangfang, Song, Hengyi, Ji, Yin, Huo, Da, Han, Feng, Li, Fei, Jiang, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718070/
https://www.ncbi.nlm.nih.gov/pubmed/33122473
http://dx.doi.org/10.7555/JBR.34.20200044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718070/
https://www.ncbi.nlm.nih.gov/pubmed/33122473
http://dx.doi.org/10.7555/JBR.34.20200044

Ejemplares similares